Physician profile
Edwin S Kwon
NPI 1326274788
$2,235.11
in general payments reported to CMS, 2019-2025
11 companies · $995 in 2025
The $995 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $21.29 · 2021: $125 · 2022: $218 · 2023: $602 · 2024: $171 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,769.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $756.63 | 2025 | |
| Merz North America, INC. | $602.31 | 2023 | Xeomin |
| Mentor Worldwide LLC | $238.64 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $183.66 | 2022-2024 | |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2021 | |
| Polynovo North America LLC | $120.67 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $57.88 | 2019 | |
| Integra Lifesciences Corporation | $52.44 | 2020-2022 | |
| Sientra, INC. | $44.29 | 2019 | |
| Allergan, INC. | $29.98 | 2022 | |
| Biotissue Holdings INC. | $23.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.